Neurobiological Technologies, Inc.
NTII
Rank in Stocks
#34780
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation... Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$2.69K
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Neurobiological Technologies, Inc. (NTII)
Category
Healthcare
Operating Margin for Neurobiological Technologies, Inc. (NTII)
Operating Margin as of November 2026 TTM: 13.25%
According to Neurobiological Technologies, Inc.'s latest financial reports, its current operating margin (TTM) is 13.25%. At the end of 2010 the company had an operating margin of 0.00%.
Operating Margin history for Neurobiological Technologies, Inc. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 13.25% | 0.00% |
| 2010 | 0.00% | -100.00% |
| 2009 | 13.25% | -111.71% |
| 2008 | -113.12% | 28.14% |
| 2007 | -88.28% | -61.01% |
| 2006 | -226.43% | -72.18% |
| 2005 | -813.90% | 839.95% |
| 2004 | -86.59% | -39.43% |
| 2003 | -142.97% | 0.00% |
| 2002 | 0.00% | -100.00% |
| 2001 | 21.57% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -181.36% | -113.69% |
US
|
|
| 38.59% | -97.09% |
US
|
|
| -149.01% | -111.25% |
US
|
|
| 25.57% | -98.07% |
AU
|
|
| 31.23% | -97.64% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Neurobiological Technologies, Inc.'s operating margin
What is Neurobiological Technologies, Inc.'s operating margin?
Neurobiological Technologies, Inc.'s operating margin is 13.25%, as of Nov 2026.
What was Neurobiological Technologies, Inc.'s operating margin in 2010?
In 2010, Neurobiological Technologies, Inc.'s operating margin was 0.00%, compared with 13.25% in 2009.
How has Neurobiological Technologies, Inc.'s operating margin changed since 2005?
From 2005 to 2010, Neurobiological Technologies, Inc.'s operating margin was highest in 2009 (13.25%) and lowest in 2005 (-813.90%).
How does Neurobiological Technologies, Inc.'s operating margin compare with similar companies?
Neurobiological Technologies, Inc.'s operating margin (13.25%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.